Aytu BioPharma (AYTU) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Aytu BioPharma Revenue Highlights

Latest Revenue (Y)

$81.00M

Latest Revenue (Q)

$16.57M

Main Segment (Y)

Consumer Health

Main Geography (Y)

UNITED STATES

Aytu BioPharma Revenue by Period

Aytu BioPharma Revenue by Year

Date	Revenue	Change
2024-06-30	$81.00M	-24.58%
2023-06-30	$107.40M	11.10%
2022-06-30	$96.67M	47.29%
2021-06-30	$65.63M	137.52%
2020-06-30	$27.63M	277.47%
2019-06-30	$7.32M	100.01%
2018-06-30	$3.66M	13.61%
2017-06-30	$3.22M	25.72%
2016-06-30	$2.56M	878.85%
2015-06-30	$261.78K	344.23%
2014-08-31	$58.93K	3267.37%
2013-08-31	$1.75K	-
2012-08-31	$1.75K	100.00%
2011-08-31	-	100.00%
2010-08-31	-	-100.00%
2009-08-31	$1.75K	100.00%
2008-08-31	-	100.00%
2007-08-31	-	-

Aytu BioPharma generated $81.00M in revenue during NA 2024, up -24.58% compared to the previous quarter, and up 1106.53% compared to the same period a year ago.

Aytu BioPharma Revenue by Quarter

Date	Revenue	Change
2024-09-30	$16.57M	-7.80%
2024-06-30	$17.98M	-0.09%
2024-03-31	$17.99M	-21.54%
2023-12-31	$22.93M	3.78%
2023-09-30	$22.10M	-28.09%
2023-06-30	$30.73M	35.19%
2023-03-31	$22.73M	-13.49%
2022-12-31	$26.28M	-4.98%
2022-09-30	$27.66M	0.75%
2022-06-30	$27.45M	13.43%
2022-03-31	$24.20M	4.64%
2021-12-31	$23.13M	5.61%
2021-09-30	$21.90M	-6.75%
2021-06-30	$23.48M	74.17%
2021-03-31	$13.48M	-10.99%
2020-12-31	$15.15M	12.03%
2020-09-30	$13.52M	-9.02%
2020-06-30	$14.86M	82.20%
2020-03-31	$8.16M	156.87%
2019-12-31	$3.18M	120.53%
2019-09-30	$1.44M	-16.07%
2019-06-30	$1.72M	-27.85%
2019-03-31	$2.38M	32.47%
2018-12-31	$1.80M	25.35%
2018-09-30	$1.43M	54.81%
2018-06-30	$925.00K	52.39%
2018-03-31	$607.00K	-42.25%
2017-12-31	$1.05M	-2.32%
2017-09-30	$1.08M	28.73%
2017-06-30	$835.89K	-6.50%
2017-03-31	$894.00K	12.59%
2016-12-31	$794.00K	13.75%
2016-09-30	$698.00K	-25.53%
2016-06-30	$937.30K	40.23%
2016-03-31	$668.43K	42.39%
2015-12-31	$469.43K	-3.68%
2015-09-30	$487.38K	167.74%
2015-06-30	$182.04K	663.93%
2015-03-31	$23.83K	-
2015-02-28	$23.83K	100.00%
2014-08-31	-	-100.00%
2014-05-31	$1.00K	100.00%
2014-02-28	-	100.00%
2013-08-31	-	-100.00%
2013-05-31	$1.75K	100.00%
2013-02-28	-	-100.00%
2012-08-31	$1.75K	100.00%
2012-05-31	-	100.00%
2012-02-29	-	100.00%
2011-08-31	-	100.00%
2011-05-31	-	100.00%
2011-02-28	-	100.00%
2010-08-31	-	100.00%
2010-05-31	-	100.00%
2009-12-31	-	100.00%
2009-08-31	-	-100.00%
2009-05-31	$1.75K	100.00%
2009-02-28	-	100.00%
2008-08-31	-	100.00%
2008-05-31	-	100.00%
2008-02-29	-	100.00%
2007-08-31	-	100.00%
2007-05-31	-	100.00%
2007-02-28	-	100.00%
2006-11-30	-	100.00%
2006-05-31	-	-

Aytu BioPharma generated $16.57M in revenue during Q1 2025, up -7.80% compared to the previous quarter, and up 53.93% compared to the same period a year ago.

Aytu BioPharma Revenue Breakdown

Aytu BioPharma Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Jun 24	Jun 22	Jun 21	Jun 20
Consumer Health	$15.82M	-	-	-
Consumer Health Portfolio	-	$35.55M	$32.95M	-
Pediatric Portfolio	-	$16.08M	$24.43M	-
Primary Care And Devices Legacy	-	-	$8.25M	-
License Revenue	-	-	-	-
Product Revenue	-	-	-	$27.63M

Aytu BioPharma's latest annual revenue breakdown by segment (product or service), as of Jun 24: Consumer Health (100.00%).

Quarterly Revenue by Product

Product/Service	Jun 24	Mar 24	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Mar 21	Dec 20	Jun 20	Mar 20	Mar 18
Consumer Health	$11.85M	$3.97M	$8.93M	$8.25M	-	-	-	-	-	-	-	-	-	-
Consumer Health Portfolio	-	-	-	-	$9.00M	$8.71M	$10.34M	$8.48M	$8.01M	-	-	-	-	-
Pediatric Portfolio	-	-	-	-	$6.56M	$-25.41M	$13.59M	$14.45M	$13.46M	-	-	-	-	-
Primary Care Portfolio	-	-	-	-	-	-	$272.00K	$192.00K	-	-	-	-	-	-
Discontinued Non-core Product	-	-	-	-	-	-	$1.70M	-	-	-	-	-	-	-
Primary Care And Devices Legacy	-	-	-	-	-	-	-	-	$425.00K	-	-	-	-	-
Aytu Bioscience	-	-	-	-	-	-	-	-	-	$5.13M	$7.21M	-	-	-
Aytu Consumer Health	-	-	-	-	-	-	-	-	-	$8.36M	$7.93M	-	-	-
Product Revenue	-	-	-	-	-	-	-	-	-	-	-	$14.86M	$8.16M	-
License Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Aytu Bioscience Inc	-	-	-	-	-	-	-	-	-	-	-	-	-	$561.00K
Aytu Womens Health	-	-	-	-	-	-	-	-	-	-	-	-	-	$46.00K

Aytu BioPharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Consumer Health (100.00%).

Aytu BioPharma Revenue Breakdown by Country

Annual Revenue by Country

Country	Jun 24	Jun 22	Jun 21
Non-US	$91.00K	$2.06M	-
UNITED STATES	$80.91M	$94.61M	-
Pediatric Portfolio	-	$16.08M	-
Consumer Health Portfolio	-	$35.55M	-
Non Us	-	-	$4.95M
U	-	-	$60.69M

Aytu BioPharma's latest annual revenue breakdown by geography, as of Jun 24: UNITED STATES (99.89%), and Non-US (0.11%).

Quarterly Revenue by Country

Country	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21
Consumer Health	$8.93M	-	-	-	-	-
UNITED STATES	-	$27.48M	$27.20M	-	-	-
Non-US	-	$179.00K	$250.00K	-	-	-
U.S.	-	-	-	$23.75M	$22.55M	-
Non Us	-	-	-	-	-	$791.00K
U	-	-	-	-	-	$21.11M

Aytu BioPharma's latest quarterly revenue breakdown by geography, as of Mar 23: Consumer Health (100.00%).

Aytu BioPharma Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PTPI	Petros Pharmaceuticals	$5.82B	$1.42M
IRWD	Ironwood Pharmaceuticals	$442.74M	$91.59M
LFCR	Lifecore Biomedical	$128.26M	$24.70M
ESPR	Esperion Therapeutics	$116.33M	$51.63M
AYTU	Aytu BioPharma	$81.00M	$16.57M
ALIM	Alimera Sciences	$80.75M	$23.01M
DERM	Journey Medical	$79.18M	$14.86M
FLGC	Flora Growth	$76.07M	$15.68M
NEPT	Neptune Wellness Solutions	$71.11M	$7.60M
AQST	Aquestive Therapeutics	$50.58M	$13.54M
SBFM	Sunshine Biopharma	$39.85M	$9.30M
AVDL	Avadel Pharmaceuticals	$27.96M	$50.02M
SNOA	Sonoma Pharmaceuticals	$12.73M	$3.39M
GHSI	Guardion Health Sciences	$12.25M	$36.35K
JUPW	Safety Shot	$6.20M	$910.01K
EVOK	Evoke Pharma	$5.18M	$2.65M
ADMP	Adamis Pharmaceuticals	$4.76M	$9.06M
SXTC	China SXT Pharmaceuticals	$1.97M	$939.58K
ACRX	Talphera	$651.00K	$117.00K
SHPH	Shuttle Pharmaceuticals	-	-

AYTU Revenue FAQ

What is Aytu BioPharma’s yearly revenue?

Aytu BioPharma's yearly revenue for 2024 was $81M, representing a decrease of -24.58% compared to 2023. The company's yearly revenue for 2023 was $107.4M, representing an increase of 11.10% compared to 2022. AYTU's yearly revenue for 2022 was $96.67M, representing an increase of 47.29% compared to 2021.

What is Aytu BioPharma’s quarterly revenue?

Aytu BioPharma's quarterly revenue for Q1 2025 was $16.57M, a -7.80% decrease from the previous quarter (Q4 2024), and a -25.00% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $17.98M, a -0.09% decrease from the previous quarter (Q3 2024), and a -41.51% decrease year-over-year (Q4 2023). AYTU's quarterly revenue for Q3 2024 was $17.99M, a -21.54% decrease from the previous quarter (Q2 2024), and a -20.85% decrease year-over-year (Q3 2023).

What is Aytu BioPharma’s revenue growth rate?

Aytu BioPharma's revenue growth rate for the last 3 years (2022-2024) was -16.21%, and for the last 5 years (2020-2024) was 193.14%.

What are Aytu BioPharma’s revenue streams?

Aytu BioPharma's revenue streams in n 24 are Consumer Health

What is Aytu BioPharma’s main source of revenue?

For the fiscal year ending Jun 24, the largest source of revenue of Aytu BioPharma was Consumer Health. This segment made a revenue of $15.82M, representing 100.00% of the company's total revenue.